NTSR1
Basic information
Region (hg38): 20:62708836-62762771
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTSR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 23 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 4 | 9 |
Variants in NTSR1
This is a list of pathogenic ClinVar variants found in the NTSR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-62709232-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
20-62709239-C-G | not specified | Uncertain significance (Jul 19, 2023) | ||
20-62709272-C-T | not specified | Uncertain significance (May 09, 2023) | ||
20-62709287-A-G | not specified | Uncertain significance (Sep 22, 2023) | ||
20-62709323-C-T | not specified | Uncertain significance (May 13, 2024) | ||
20-62709324-G-A | Benign (Jun 11, 2018) | |||
20-62709342-C-T | Benign (Apr 26, 2018) | |||
20-62709368-T-C | not specified | Uncertain significance (Oct 05, 2022) | ||
20-62709380-C-T | Benign (Apr 07, 2018) | |||
20-62709422-C-T | Benign (Mar 29, 2018) | |||
20-62709446-G-A | not specified | Uncertain significance (Mar 23, 2022) | ||
20-62709502-A-G | not specified | Uncertain significance (Mar 21, 2023) | ||
20-62709539-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
20-62709549-C-T | Likely benign (Jul 02, 2018) | |||
20-62709563-C-T | not specified | Uncertain significance (Jun 22, 2024) | ||
20-62709671-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
20-62709758-G-T | not specified | Uncertain significance (Dec 01, 2022) | ||
20-62709851-A-G | not specified | Uncertain significance (Jan 26, 2022) | ||
20-62709908-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
20-62709910-G-A | not specified | Uncertain significance (Sep 29, 2023) | ||
20-62754748-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
20-62754795-A-C | Benign (Jun 10, 2018) | |||
20-62754814-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
20-62754852-G-T | not specified | Uncertain significance (Sep 22, 2023) | ||
20-62754865-C-T | not specified | Uncertain significance (Jun 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NTSR1 | protein_coding | protein_coding | ENST00000370501 | 4 | 53935 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.93e-8 | 0.251 | 125667 | 0 | 81 | 125748 | 0.000322 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.416 | 310 | 290 | 1.07 | 0.0000197 | 2668 |
Missense in Polyphen | 128 | 105.59 | 1.2122 | 1059 | ||
Synonymous | 0.663 | 132 | 142 | 0.929 | 0.0000108 | 901 |
Loss of Function | 0.494 | 13 | 15.1 | 0.863 | 9.24e-7 | 133 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000552 | 0.000540 |
Ashkenazi Jewish | 0.00201 | 0.00199 |
East Asian | 0.000224 | 0.000217 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.000306 | 0.000299 |
Middle Eastern | 0.000224 | 0.000217 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.000495 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: G-protein coupled receptor for the tridecapeptide neurotensin (NTS) (PubMed:8381365, PubMed:21725197, PubMed:23140271). Signaling is effected via G proteins that activate a phosphatidylinositol-calcium second messenger system. Signaling leads to the activation of downstream MAP kinases and protects cells against apoptosis (PubMed:21725197). {ECO:0000269|PubMed:21725197, ECO:0000269|PubMed:23140271, ECO:0000269|PubMed:8381365}.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Other;Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.311
Intolerance Scores
- loftool
- 0.887
- rvis_EVS
- 0.67
- rvis_percentile_EVS
- 84.7
Haploinsufficiency Scores
- pHI
- 0.177
- hipred
- N
- hipred_score
- 0.239
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.927
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ntsr1
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- temperature homeostasis;negative regulation of systemic arterial blood pressure;regulation of membrane depolarization;G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;chemical synaptic transmission;learning;adult locomotory behavior;positive regulation of glutamate secretion;positive regulation of gamma-aminobutyric acid secretion;response to lipid;positive regulation of apoptotic process;negative regulation of apoptotic process;regulation of respiratory gaseous exchange;detection of temperature stimulus involved in sensory perception of pain;negative regulation of release of sequestered calcium ion into cytosol;positive regulation of release of sequestered calcium ion into cytosol;regulation of sensory perception of pain;positive regulation of inositol phosphate biosynthetic process;D-aspartate import across plasma membrane;inositol phosphate catabolic process;positive regulation of arachidonic acid secretion;positive regulation of inhibitory postsynaptic potential;L-glutamate import across plasma membrane;regulation of action potential;positive regulation of cation channel activity
- Cellular component
- mitochondrion;endoplasmic reticulum;Golgi apparatus;plasma membrane;integral component of plasma membrane;cytoplasmic side of plasma membrane;cell surface;symmetric synapse;terminal bouton;dendritic spine;dendritic shaft;perikaryon;membrane raft
- Molecular function
- G protein-coupled receptor activity;protein binding;G protein-coupled neurotensin receptor activity;identical protein binding;protein homodimerization activity;protein heterodimerization activity;protein N-terminus binding